@FiercePharma: Now armed with EU nod for Lemtrada, Sanofi preps to launch its multiple sclerosis duo (with Aubagio). Release (PDF) | Follow @FiercePharma
@CarlyHFierce: Whistleblower codenamed Zorro implicates Novartis' Alcon division in Chinese bribery scandal. More from The Financial Times | Follow @CarlyHFierce
> Actavis ($ACT) launched its version of the Endo Pharmaceuticals ($ENDP) pain patch Lidoderm. Report
> Sanofi ($SNY) alerted U.K. doctors to a batch of Plavix patients that developed the rare autoimmune disease acquired hemophilia. Report
> Daiichi Sankyo stock plummeted after the FDA restricted imports from its Indian generics unit, Ranbaxy Laboratories. Report
> The German pharma company Aenova raised €130 million ($175 million) in financing to back its planned buyout of the contract manufacturer Haupt Pharma, Reuters reports. Report
> Bayer is amping up cost-cutting plans at its plastics unit at a time when its pharma business is delivering decent growth. Report
@FierceMedDev: Special Report: 'Big' med tech M&A deals getting smaller. Feature | Follow @FierceMedDev
@DamianFierce: VisionCare landed up to $15M to market its AMD-treating eye implant. News | Follow @DamianFierce
@MarkHFierce: The U.S. will now have the first permanent implant designed to treat enlarged prostates. Expect a gradual launch. ICYMI yesterday | Follow @MarkHFierce
@MichaelGFierce: Abbott snags CE mark for diabetes monitor. Item | Follow @MichaelGFierce
> Europe risks more delays on device reg reform. More
> Medtronic cuts ribbon on $10M Irish R&D shop. Story
> Boston Scientific debuts teaching, R&D centers in China. Article
Biotech News
@FierceBiotech: ICYMI yesterday: CDC director warns antibiotics pipeline 'nearly empty.' Story | Follow @FierceBiotech
@JohnCFierce: Regado CEO moves the goal line after a rare biotech IPO misfire. More | Follow @JohnCFierce
> Biotechs keep the cash pumping (for now) with more IPOs and ATMs. Story
> On a roll, Boehringer wins 'breakthrough' status for pioneering leukemia drug. News
> Broker's Facebook rant on biotech stock draws $5K fine. Item
Pharma Manufacturing News
@EricPFierce: Now that Ranbaxy's Mohali plant falls under FDA consent decree, oversight ramps up significantly. Article | Follow @EricPFierce
> Cargill invests $15M in French alginate plant. Item
> Hospira recalls bupivacaine because of steel particles in vials. Story
> Strides gets FDA warning for plant Mylan is buying. More
> J&J sues Ben Venue over Doxil shortage. Report
Biotech Research News
@EmilyMFierce: Initial focus of BRAIN Initiative laid out, but are the goals any clearer than they were in April? Check out the story and weigh in | Follow @EmilyMFierce
> Visterra antibody shows promise in preclinical study as universal flu vaccine. Item
> NIH partners with Eli Lilly, others on rare diseases. Article
> Experimental vaccine clears monkeys of HIV-like virus. More
> Genia Technologies, Columbia, Harvard nab $5.3M NIH grant for genome sequencing. Story
And Finally... Drug-resistant bacteria are becoming a "nightmare," with urgent threats seen in three diseases. Report